When it comes to paracetamol tablet formulation, one decision continues to influence both performance and production efficiency Direct Compression (DC) vs. Wet Granulation. For formulation scientists and procurement teams, this is not just a technical choice, but a strategic one that impacts cost, scalability, and consistency.

Paracetamol has long been known for its poor flowability and compressibility, which is why wet granulation became the industry standard.
However, with the development of engineered Paracetamol DC grades, the industry is steadily re-evaluating this approach.

Understanding the Difference

Wet granulation is a multi-step process where powders are bound using a liquid, dried, and then compressed into tablets. It is reliable and widely accepted, especially for formulations where mechanical strength is critical. The process helps improve powder flow and compressibility, which is particularly useful for high-dose APIs like paracetamol.

However, this reliability comes at a cost. Wet granulation introduces additional steps, longer production cycles, and exposure to moisture and heat all of which can affect efficiency and, in some cases, API stability.

Direct compression, on the other hand, simplifies manufacturing to just blending and compression. With modern Paracetamol DC, the API is engineered to overcome traditional limitations, allowing formulators to achieve consistent performance without the need for granulation.

How They Compare in Practice

The real difference between these two methods becomes clear on the production floor.

Wet granulation delivers strong tablets and is often preferred when formulations demand high mechanical robustness. In fact, granulated formulations tend to produce harder tablets and better compressibility under certain conditions.

But this strength often comes with slower dissolution and longer processing times. Studies show that tablets produced via wet granulation can exhibit slower drug release profiles compared to directly compressed formulations.

Direct compression, particularly with optimized Paracetamol DC, offers a different advantage. It enables faster manufacturing, improved weight uniformity, and more predictable dissolution. It also eliminates moisture and heat exposure, which enhances stability and simplifies scale-up.

From a commercial perspective, fewer steps translate directly into lower operational costs and faster turnaround times a critical factor in today’s competitive manufacturing environment.

Choosing the Right Approach

There isn’t a one-size-fits-all answer. The choice depends on what your formulation demands.

If your priority is maximum tablet hardness in high drug-load formulations, wet granulation still holds value. But if you are looking to streamline operations, improve batch consistency, and reduce manufacturing complexity, direct compression becomes a compelling option.

Increasingly, the industry is shifting toward DC-based formulations not because wet granulation is outdated, but because modern API engineering has made direct compression far more viable than before.

At Farmson Basic Drugs, we recognise that the success of a tablet begins with the right API form.

Our Paracetamol DC is designed to deliver consistent flow, compressibility, and performance — helping you reduce processing steps without compromising on quality. It supports high-speed tableting and enables more predictable outcomes across batches.

Whether you are reformulating or scaling up, our team works closely with you to align API characteristics with your manufacturing goals.

Explore more: https://www.farmson.com/products/paracetamol-dc